Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LaMB: Maintenance Lapatinib in HER1/HER2+ Advanced Bladder Cancer
NCT00949455Phase 3Unknown
- Sponsor
- Queen Mary University of London
- Start
- Mar 2009
- Primary completion
- Jul 2015
- Countries
- 1
01
Overview
A Phase 3 trial of lapatinib in bladder cancer, sponsored by Queen Mary University of London. Status: unknown.
02
Drugs
lapatinib
03
Conditions
bladder cancer
Beyond the preview
Go deeper on NCT00949455.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00949455.